Using antibiotic concentrations in middle ear fluid to predict potential clinical efficacy

Pediatric Infectious Disease Journal

Volumn 16, Issue 2 SUPPL., 1997, Pages

  Harrison, Christopher J ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antibiotics; middle ear fluid; pharmacokinetics; Tympanocentesis

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFIXIME; CEFPODOXIME PROXETIL; CEFTIBUTEN; CEFUROXIME AXETIL; CLINDAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG PENETRATION; DRUG POTENCY; FOLLOW UP; HAEMOPHILUS INFLUENZAE; HUMAN; MIDDLE EAR; MYRINGOTOMY; OTITIS MEDIA; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, MICROBIAL; EXUDATES AND TRANSUDATES; HUMANS; MICROBIAL SENSITIVITY TESTS; OTITIS MEDIA WITH EFFUSION;

EID: 0031052049     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199702001-00004     Document Type: Article

References (25)

1. Sundberg L, Edén T. Penetration of enoxacin into middle ear effusion. Acta Otolaryngol (Stockh) 1990;109:438-43.
2. Edén T. Long-standing otitis media with effusion: a convenient model for the study of antibiotic penetration to respiratory tract secretions. Scand J Infect Dis 1985;44(Suppl): 46-51.
3. Shyu WC, Haddad J, Reilly J, et al. Penetration of cefprozil into middle ear fluid of patients with otitis media. Antimicrob Agents Chemother 1994;38:2210-12.
4. Harrison CJ, Belhorn TH. Antibiotic treatment failures in acute otitis media. Pediatr Ann 1991;20:600-8.
5. Chonmaitree T, Owen MJ, Howie VM. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J Infect Dis 1990;162:546-9.
6. Sundberg L, Cederberg A. Penetration of clarithromycin and its 14-hydroxy metabolite into middle ear effusion in children with secretory otitis media. J Antimicrob Chemother 1994; 33:299-307.
7. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J 1993;12:973-5.
8. Harrison CJ, Marks MI, Welch DF. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media. Pediatr Infect Dis 1985;4:641-6.
9. Chonmaitree T, Owen MJ, Patel JA, Hedgpeth D, Horlick D, Howie VM. Effect of viral respiratory tract infection on outcome of acute otitis media. J Pediatr 1992;120:856-62.
10. Howie VM, Ploussard JH. The "in vivo sensitivity test": bacteriology of middle ear exudate during antimicrobial* therapy in otitis media. Pediatrics 1969;44:940-4.
11. Wiedermann BL, Schwartz RH. Effect of blood contamination on the interpretation of antibiotic concentrations in middle ear fluid [Letter]. Pediatr Infect Dis J 1992;11:244-5.
12. Harrison CJ, Chartrand SA, Rodriguez W, et al. Middle ear fluid (MEF) concentrations of cefixime (Cfxm) in acute otitis media (AOM) and otitis media with effusion (OME) [Abstract]. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1994;71.
13. Canafax DM, Giebink GS. Antimicrobial treatment of acute otitis media. Ann Otol Rhinol Laryngol 1994;103:11-14.
14. Harrison CJ, Chartrand SA, Pichichero ME. Microbiologic and clinical aspects of a trial of once daily cefixime compared with twice daily cefaclor for treatment of acute otitis media in infants and children. Pediatr Infect Dis J 1993;12:62-9.
15. Craig WA. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis 1995;22:89-96.
16. Nelson CT, Mason EO Jr, Kaplan SL. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin-resistant Streptococcus pneumoniae: implications for treatment. Pediatr Infect Dis J 1994;13:585-9.
17. Canafax DM, Nonomura N, Erdmann GR, Le CT, Juhn SK, Giebink GS. Experimental animal models for studying antimicrobial pharmacokinetics in otitis media. Pharm Res 1989; 6:279-85.
18. Harrison CJ. Rational selection of antimicrobials for pediatric upper respiratory infections. Pediatr Infect Dis J 1995;14: S121-9.
19. Fraschini F, Scaglione F, Demartini G. Clarithromycin clinical pharmacokinetics. Clin Pharmacokinet 1993;25:189-204.
20. Lalak NJ, Morris DL. Azithromycin clinical pharmacokinetics. Clin Pharmacokinet 1993;25:370-4.
21. Wise R. The pharmacokinetics of the oral cephalosporins: a review. J Antimicrob Chemother 1990;26(Suppl E):13-20.
22. Patel JA, Reisner B, Vizirinia N, Owen M, Chonmaitree T, Howie V. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J Pediatr 1995;126:799-806.
23. Owen MJ, Anwar R, Nguyen HK, Swank PR, Bannister ER, Howie VM. Efficacy of cefixime in the treatment of acute otitis media in children. Am J Dis Child 1993;147:81-6.
24. Indication and usage, upper respiratory tract, otitis media. Physician's desk reference. 50th ed. Montvale, NJ: Medical Economics Data, 1996:746.
25. Dagan R, Abramson O, Leibovitz E, et al. Impaired bacteriologic response to oral cephalosporins in acute otitis media (AOM) caused by intermediately penicillin-resistant pneumococci (I-PRP) [Abstract]. Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (Program Addendum). Washington, DC: American Society for Microbiology, 1995;12.